United States · FDA National Drug Code directory
topotecan hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16729-151_23a75b4a-a836-a01d-e063-6394a90a67b3
- Product NDC
- 16729-151
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- topotecan hydrochloride
- Labeler
- Accord Healthcare, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130723
- Source listing expiry
- 20261231
Source-listed ingredients
- TOPOTECAN HYDROCHLORIDE — 4 mg/4mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 PACKAGE (16729-151-31) / 4 mL in 1 VIAL · 16729-151-31
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →